One step closer to commercialisation for Recce Pharma
One step closer to commercialisation for Recce Pharma
General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.
About this video
Recce Pharmaceuticals has been granted an anti-viral patent for its anti-infectives drug. CEO James Graham says the news takes the company one step closer to commercialisation.
More like this
4:51
Recce strengthens its patent armour14 July 20263:58
Market Update | Oil & Energy Stocks, Gold, Steadfast, Origin Energy, SK Hynix, Ryman Healthcare, Recce, Coronado Global Resources14 July 2026 · GMD, ORG, RYM, SDF52:34
the callthe call: 30th March | RCE ORA DUR VAU SFR 360 KPG IFL WEB SM130 Mar 2026 · 360, IFL, ORA, SFR0:56
Market Update | Pro Medicus, Insurance Australia Group, Credit Corp, Dyno Nobel, Worley, Caterpillar, RPM Global, Genesis Minerals, Virgin Australia, Austal, Bapcor, Harvey Norman, Activeport, Megaport, Recce Pharmaceuticals, 4D Medical1 Sept 2025 · 4DX, ASB, DNL, GMD